Confirmation of efficacy and safety of acoustic CR®-neuromodulation for the treatment of chronic tinnitus patients using the CE marked ANM T30 CR®-system in a real life outpatient setting.
Estimated Enrollment: 200
- Identification of early indicators for therapy success
- Comparison of different patient groups regarding: tinnitus severity, tinnitus duration, level of hearing loss, stimulation patterns, unilateral monotonal vs. all other complex forms
- Representative set of safety data in a broad patient spectrum
- Measurement of tinnitus burden (TBF-12 Questionnaire)
- Generation of longterm compliance data
Study Start Date: November 2011
Estimated Study Completion Date: July 2013
Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
Acoustic Coordinated Reset (CR®) Neuromodulation for the Treatment of Chronic Tonal Tinnitus
Confirmation of efficacy and safety of acoustic CR neuromodulation for the treatment of tinnitus.